Innovative Therapies for Eye Diseases

SELAGINE, Inc. develops novel topical biologic immunotherapies for treatment of immunological and inflammatory ocular surface diseases such as Sjögren’s syndrome and ocular Graft-versus-Host Disease.

SELAGINE

SELAGINE Inc, 2201 W. Campbell Park Drive, MB: 26, Chicago,  IL 60612